Melinda G. Gunnell

537 total citations
22 papers, 450 citations indexed

About

Melinda G. Gunnell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Toxicology. According to data from OpenAlex, Melinda G. Gunnell has authored 22 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 8 papers in Toxicology. Recurrent topics in Melinda G. Gunnell's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Forensic Toxicology and Drug Analysis (8 papers) and Receptor Mechanisms and Signaling (5 papers). Melinda G. Gunnell is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Forensic Toxicology and Drug Analysis (8 papers) and Receptor Mechanisms and Signaling (5 papers). Melinda G. Gunnell collaborates with scholars based in United States. Melinda G. Gunnell's co-authors include S. Michael Owens, F. Ivy Carroll, Eric C. Peterson, Bruce E. Blough, Susan R. Shelnutt, Elizabeth M. Laurenzana, D. E. McMillan, Daniela Rüedi‐Bettschen, Huimin Liu and Peter Abraham and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

Melinda G. Gunnell

22 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melinda G. Gunnell United States 13 220 209 148 101 89 22 450
Samuel A. Roiko United States 13 198 0.9× 153 0.7× 115 0.8× 47 0.5× 70 0.8× 15 466
Clara T. Schoeder Germany 15 284 1.3× 191 0.9× 170 1.1× 23 0.2× 277 3.1× 41 680
Candy S. Hwang United States 14 135 0.6× 253 1.2× 130 0.9× 21 0.2× 138 1.6× 21 498
Diwahar Narasimhan United States 14 212 1.0× 201 1.0× 156 1.1× 17 0.2× 146 1.6× 19 457
Ashli M. Tucker United States 7 123 0.6× 148 0.7× 84 0.6× 22 0.2× 76 0.9× 9 350
Morgan Le Naour United States 8 166 0.8× 225 1.1× 98 0.7× 13 0.1× 99 1.1× 10 402
G. Neil Stowe United States 9 97 0.4× 129 0.6× 120 0.8× 21 0.2× 63 0.7× 14 323
Trevor I. Prior Canada 11 206 0.9× 66 0.3× 14 0.1× 36 0.4× 90 1.0× 14 732
Stephen Espitia United States 12 239 1.1× 248 1.2× 11 0.1× 13 0.1× 171 1.9× 17 703
Charlotte E. Farquhar United States 12 144 0.7× 145 0.7× 94 0.6× 37 0.4× 216 2.4× 17 392

Countries citing papers authored by Melinda G. Gunnell

Since Specialization
Citations

This map shows the geographic impact of Melinda G. Gunnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda G. Gunnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda G. Gunnell more than expected).

Fields of papers citing papers by Melinda G. Gunnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melinda G. Gunnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda G. Gunnell. The network helps show where Melinda G. Gunnell may publish in the future.

Co-authorship network of co-authors of Melinda G. Gunnell

This figure shows the co-authorship network connecting the top 25 collaborators of Melinda G. Gunnell. A scholar is included among the top collaborators of Melinda G. Gunnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda G. Gunnell. Melinda G. Gunnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morrison, Louise F., et al.. (2024). Limited bedding and nesting increases ethanol drinking in female rats. Pharmacology Biochemistry and Behavior. 239. 173756–173756. 3 indexed citations
2.
Gunnell, Melinda G., et al.. (2021). Pharmacokinetics of α-Pyrrolidinovalerophenone in Male Rats with and without Vaccination with an α-Pyrrolidinovalerophenone Vaccine. Journal of Pharmacy & Pharmaceutical Sciences. 24. 267–276. 3 indexed citations
3.
Gunnell, Melinda G., et al.. (2020). Active vaccination reduces reinforcing effects of MDPV in male Sprague-Dawley rats trained to self-administer cocaine. Psychopharmacology. 237(9). 2613–2620. 3 indexed citations
4.
Kormos, Chad M., Melinda G. Gunnell, Frank I. Carroll, et al.. (2019). Design, synthesis and biological evaluation of a bi-specific vaccine against α-pyrrolidinovalerophenone (α-PVP) and 3,4-methylenedioxypyrovalerone (MDPV) in rats. Vaccine. 38(2). 336–344. 4 indexed citations
5.
Gunnell, Melinda G., et al.. (2019). Cardiovascular effects of 3,4-methylenedioxypyrovalerone (MDPV) in male and female Sprague-Dawley rats. Drug and Alcohol Dependence. 195. 140–147. 16 indexed citations
6.
Rüedi‐Bettschen, Daniela, et al.. (2019). Antibody production and pharmacokinetics of METH in rats following vaccination with the METH vaccine, IXT-v100, adjuvanted with GLA-SE. Drug and Alcohol Dependence. 204. 107484–107484. 3 indexed citations
7.
McGill, Mitchell R., et al.. (2019). Effect of Bile Duct Ligation-induced Liver Dysfunction on Methamphetamine Pharmacokinetics and Locomotor Activity in Rats. Journal of Pharmacy & Pharmaceutical Sciences. 22(1). 301–312. 6 indexed citations
8.
Hendrickson, Howard P., et al.. (2017). The pharmacokinetics of racemic MDPV and its (R) and (S) enantiomers in female and male rats. Drug and Alcohol Dependence. 179. 347–354. 22 indexed citations
9.
Gunnell, Melinda G., et al.. (2016). Optimization of a methamphetamine conjugate vaccine for antibody production in mice. International Immunopharmacology. 35. 137–141. 27 indexed citations
10.
Rüedi‐Bettschen, Daniela, et al.. (2016). Chronic treatment of (+)-methamphetamine-induced locomotor effects in rats using one or a combination of two high affinity anti-methamphetamine monoclonal antibodies. Human Vaccines & Immunotherapeutics. 12(9). 2240–2248. 7 indexed citations
11.
Rüedi‐Bettschen, Daniela, Melinda G. Gunnell, Charles West, et al.. (2013). Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food. Vaccine. 31(41). 4596–4602. 45 indexed citations
12.
Carroll, F. Ivy, Bruce E. Blough, Philip Abraham, et al.. (2011). Synthesis of Mercapto-(+)-methamphetamine Haptens and Their Use for Obtaining Improved Epitope Density on (+)-Methamphetamine Conjugate Vaccines. Journal of Medicinal Chemistry. 54(14). 5221–5228. 37 indexed citations
13.
Gunnell, Melinda G., et al.. (2007). Engineering and characterization of a mouse/human chimeric anti-phencyclidine monoclonal antibody. International Immunopharmacology. 8(1). 1–11. 9 indexed citations
14.
Peterson, Eric C., Melinda G. Gunnell, Robyn L. Goforth, et al.. (2007). Using Hapten Design to Discover Therapeutic Monoclonal Antibodies for Treating Methamphetamine Abuse. Journal of Pharmacology and Experimental Therapeutics. 322(1). 30–39. 61 indexed citations
15.
16.
McMillan, D. E., et al.. (2004). Effects of Murine-Derived Anti-Methamphetamine Monoclonal Antibodies on (+)-Methamphetamine Self-Administration in the Rat. Journal of Pharmacology and Experimental Therapeutics. 309(3). 1248–1255. 59 indexed citations
17.
Laurenzana, Elizabeth M., Melinda G. Gunnell, W. Brooks Gentry, & S. Michael Owens. (2003). Treatment of Adverse Effects of Excessive Phencyclidine Exposure in Rats with a Minimal Dose of Monoclonal Antibody. Journal of Pharmacology and Experimental Therapeutics. 306(3). 1092–1098. 22 indexed citations
18.
Shelnutt, Susan R., Melinda G. Gunnell, & S. Michael Owens. (1999). Sexual Dimorphism in Phencyclidine In Vitro Metabolism and Pharmacokinetics in Rats. Journal of Pharmacology and Experimental Therapeutics. 290(3). 1292–1298. 36 indexed citations
19.
Owens, S. Michael, Melinda G. Gunnell, Elizabeth M. Laurenzana, & J L Valentine. (1993). Dose- and time-dependent changes in phencyclidine metabolite covalent binding in rats and the possible role of CYP2D1.. Journal of Pharmacology and Experimental Therapeutics. 265(3). 1261–1266. 13 indexed citations
20.
Owens, S. Michael, et al.. (1988). Antibodies against arylcyclohexylamines and their similarities in binding specificity with the phencyclidine receptor.. Journal of Pharmacology and Experimental Therapeutics. 246(2). 472–478. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel A. Roiko Breakdown of academic impact, for papers by Clara T. Schoeder Breakdown of academic impact, for papers by Candy S. Hwang Breakdown of academic impact, for papers by Diwahar Narasimhan Breakdown of academic impact, for papers by Ashli M. Tucker Breakdown of academic impact, for papers by Morgan Le Naour Breakdown of academic impact, for papers by G. Neil Stowe Breakdown of academic impact, for papers by Trevor I. Prior Breakdown of academic impact, for papers by Stephen Espitia Breakdown of academic impact, for papers by Charlotte E. Farquhar
Rankless by CCL
2026